KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Cash & Equivalents (2016 - 2025)

Precigen (PGEN) has disclosed Cash & Equivalents for 15 consecutive years, with $30.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 2.43% to $30.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.2 million through Dec 2025, up 2.43% year-over-year, with the annual reading at $30.2 million for FY2025, 2.43% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $30.2 million at Precigen, up from $14.3 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $43.8 million in Q2 2022, with the low at $4.9 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $21.5 million, with a median of $17.0 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents crashed 86.66% in 2022, then soared 289.51% in 2024.
  • Over 5 years, Cash & Equivalents stood at $36.4 million in 2021, then plummeted by 86.66% to $4.9 million in 2022, then skyrocketed by 55.99% to $7.6 million in 2023, then skyrocketed by 289.51% to $29.5 million in 2024, then rose by 2.43% to $30.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $30.2 million, $14.3 million, and $13.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.